FGF9 can induce endochondral ossification in cranial mesenchyme

BMC Developmental Biology

Volumn 6, Issue , 2006, Pages

  Govindarajan, Venkatesh ^a   Overbeek, Paul A ^b  

^a CREIGHTON UNIVERSITY   (United States)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN TYPE 10; COLLAGEN TYPE 10A1; COLLAGEN TYPE 2; COLLAGEN TYPE 2A1; FIBROBLAST GROWTH FACTOR; FIBROBLAST GROWTH FACTOR 9; OSTEOCALCIN; SONIC HEDGEHOG PROTEIN; TRANSCRIPTION FACTOR RUNX2; TRANSCRIPTION FACTOR SOX9; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CARTILAGE; CELL FATE; CONTROLLED STUDY; ENCHONDRAL OSSIFICATION; FRONTAL BONE; MESENCHYME; MESODERM; MOUSE; NONHUMAN; OSTEOBLAST; SKULL; TRANSGENIC MOUSE;

ANIMALIA; ERINACEIDAE; MUS MUSCULUS;

EID: 33644865499     PISSN: 1471213X     EISSN: 1471213X     Source Type: Journal    
DOI: 10.1186/1471-213X-6-7     Document Type: Article

References (51)

1. de Crombrugghe B, Lefebvre V, Nakashima K: Regulatory mechanisms in the pathways of cartilage and bone formation. Curr Opin Cell Biol 2001, 13(6):721-728.
2. Gerber HP, Vu TH, Ryan AM, Kowalski J, Werb Z, Ferrara N: VEGF couples hypertrophic cartilage remodeling, ossification and angiogenesis during endochondral bone formation. Nat Med 1999, 5(6):623-628.
3. Olsen BR, Reginato AM, Wang W: Bone development. Annu Rev Cell Dev Biol 2000, 16:191-220.
4. Naski MC, Ornitz DM: FGF signaling in skeletal development. Front Biosci 1998, 3:D781-94.
5. Ornitz DM, Itoh N: Fibroblast growth factors. Genome Biol 2001, 2(3):.
6. Iseki S, Wilkie AO, Morriss-Kay GM: Fgfr1 and Fgfr2 have distinct differentiation- and proliferation- related roles in the developing mouse skull vault. Development 1999, 126(24):5611-5620.
7. Rice DP, Aberg T, Chan Y, Tang Z, Kettunen PJ, Pakarinen L, Maxson RE, Thesleff I: Integration of FGF and TWIST in calvarial bone and suture development. Development 2000, 127(9):1845-1855.
8. Ornitz DM, Marie PJ: FGF signaling pathways in endochondral and intramembranous bone development and human genetic disease. Genes Dev 2002, 16(12):1446-1465.
9. Kannan K, Givol D: FGF receptor mutations: dimerization syndromes, cell growth suppression, and animal models. IUBMB Life 2000, 49(3):197-205.
10. Wang Y, Xiao R, Yang F, Karim BO, Iacovelli AJ, Cai J, Lerner CP, Richtsmeier JT, Leszl JM, Hill CA, Yu K, Ornitz DM, Elisseeff J, Huso DL, Jabs EW: Abnormalities in cartilage and bone development in the Apert syndrome FGFR2(+/S252W) mouse. Development 2005, 132(15):3537-3548.
11. Yu K, Ornitz DM: Uncoupling fibroblast growth factor receptor 2 ligand binding specificity leads to Apert syndrome-like phenotypes. Proc Natl Acad Sci U S A 2001, 98(7):3641-3643.
12. Wang Q, Green RP, Zhao G, Ornitz DM: Differential regulation of endochondral bone growth and joint development by FGFR1 and FGFR3 tyrosine kinase domains. Development 2001, 128(19):3867-3876.
13. Eswarakumar VP, Monsonego-Ornan E, Pines M, Antonopoulou I, Morriss-Kay GM, Lonai P: The IIIc alternative of Fgfr2 is a positive regulator of bone formation. Development 2002, 129(16):3783-3793.
14. Deng C, Wynshaw-Boris A, Zhou F, Kuo A, Leder P: Fibroblast growth factor receptor 3 is a negative regulator of bone growth. Cell 1996, 84(6):911-921.
15. Ornitz DM: Regulation of chondrocyte growth and differentiation by fibroblast growth factor receptor 3. Novartis Found Symp 2001, 232:63-76.
16. Kim HJ, Rice DP, Kettunen PJ, Thesleff I: FGF-, BMP- and Shh-mediated signalling pathways in the regulation of cranial suture morphogenesis and calvarial bone development. Development 1998, 125(7):1241-1251.
17. Sarkar S, Petiot A, Copp A, Ferretti P, Thorogood P: FGF2 promotes skeletogenic differentiation of cranial neural crest cells. Development 2001, 128(11):2143-2152.
18. Colvin JS, Feldman B, Nadeau JH, Goldfarb M, Ornitz DM: Genomic organization and embryonic expression of the mouse fibroblast growth factor 9 gene. Dev Dyn 1999, 216(1):72-88.
19. deLapeyriere O, Ollendorff V, Planche J, Ott MO, Pizette S, Coulier F, Birnbaum D: Expression of the Fgf6 gene is restricted to developing skeletal muscle in the mouse embryo. Development 1993, 118(2):601-611.
20. Finch PW, Cunha GR, Rubin JS, Wong J, Ron D: Pattern of keratinocyte growth factor and keratinocyte growth factor receptor expression during mouse fetal development suggests a role in mediating morphogenetic mesenchymal-epithelial interactions. Dev Dyn 1995, 203(2):223-240.
21. Haub O, Goldfarb M: Expression of the fibroblast growth factor-5 gene in the mouse embryo. Development 1991, 112(2):397-406.
22. Mason IJ, Fuller-Pace F, Smith R, Dickson C: FGF-7 (keratinocyte growth factor) expression during mouse development suggests roles in myogenesis, forebrain regionalisation and epithelial-mesenchymal interactions. Mech Dev 1994, 45(1):15-30.
23. Savage MP, Fallon JF: FGF-2 mRNA and its antisense message are expressed in a developmentally specific manner in the chick limb bud and mesonephros. Dev Dyn 1995, 202(4):343-353.
24. Colvin JS, Green RP, Schmahl J, Capel B, Ornitz DM: Male-to-female sex reversal in mice lacking fibroblast growth factor 9. Cell 2001, 104(6):875-889.
25. Colvin JS, White AC, Pratt SJ, Ornitz DM: Lung hypoplasia and neonatal death in Fgf9-null mice identify this gene as an essential regulator of lung mesenchyme. Development 2001, 128(11):2095-2106.
26. Fiore F, Planche J, Gibier P, Sebille A, deLapeyriere O, Birnbaum D: Apparent normal phenotype of Fgf6-/- mice. Int J Dev Biol 1997, 41(4):639-642.
27. Guo L, Degenstein L, Fuchs E: Keratinocyte growth factor is required for hair development but not for wound healing. Genes Dev 1996, 10(2):165-175.
28. Hebert JM, Rosenquist T, Gotz J, Martin GR: FGF5 as a regulator of the hair growth cycle: evidence from targeted and spontaneous mutations. Cell 1994, 78(6):1017-1025.
29. Lovicu FJ, Overbeek PA: Overlapping effects of different members of the FGF family on lens fiber differentiation in transgenic mice. Development 1998, 125(17):3365-3377.
30. Zhao S, Hung FC, Colvin JS, White A, Dai W, Lovicu FJ, Ornitz DM, Overbeek PA: Patterning the optic neuroepithelium by FGF signaling and Ras activation. Development 2001, 128(24):5051-5060.
31. Bi W, Deng JM, Zhang Z, Behringer RR, de Crombrugghe B: Sox9 is required for cartilage formation. Nat Genet 1999, 22(1):85-89.
32. Lefebvre V, Huang W, Harley VR, Goodfellow PN, de Crombrugghe B: SOX9 is a potent activator of the chondrocyte-specific enhancer of the pro alpha1(II) collagen gene. Mol Cell Biol 1997, 17(4):2336-2346.
33. Ducy P, Zhang R, Geoffroy V, Ridall AL, Karsenty G: Osf2/Cbfa1: a transcriptional activator of osteoblast differentiation. Cell 1997, 89(5):747-754.
34. Ducy P, Schinke T, Karsenty G: The osteoblast: a sophisticated fibroblast under central surveillance. Science 2000, 289(5484):1501-1504.
35. Couly GF, Coltey PM, Le Douarin NM: The triple origin of skull in higher vertebrates: a study in quail-chick chimeras. Development 1993, 117(2):409-429.
36. Jiang X, Iseki S, Maxson RE, Sucov HM, Morriss-Kay GM: Tissue origins and interactions in the mammalian skull vault. Dev Biol 2002, 241(1):106-116.
37. Noden DM: Interactions and fates of avian craniofacial mesenchyme. Development 1988, 103 Suppl:121-140.
38. Danielian PS, Muccino D, Rowitch DH, Michael SK, McMahon AP: Modification of gene activity in mouse embryos in utero by a tamoxifen-inducible form of Cre recombinase. Curr Biol 1998, 8(24):1323-1326.
39. Soriano P: Generalized lacZ expression with the ROSA26 Cre reporter strain. Nat Genet 1999, 21(1):70-71.
40. Chai Y, Jiang X, Ito Y, Bringas PJ, Han J, Rowitch DH, Soriano P, McMahon AP, Sucov HM: Fate of the mammalian cranial neural crest during tooth and mandibular morphogenesis. Development 2000, 127(8):1671-1679.
41. Jiang X, Rowitch DH, Soriano P, McMahon AP, Sucov HM: Fate of the mammalian cardiac neural crest. Development 2000, 127(8):1607-1616.
42. Murakami S, Kan M, McKeehan WL, de Crombrugghe B: Up-regulation of the chondrogenic Sox9 gene by fibroblast growth factors is mediated by the mitogen-activated protein kinase pathway. Proc Natl Acad Sci U S A 2000, 97(3):1113-1118.
43. Garofalo S, Kliger-Spatz M, Cooke JL, Wolstin O, Lunstrum GP, Moshkovitz SM, Horton WA, Yayon A: Skeletal dysplasia and defective chondrocyte differentiation by targeted overexpression of fibroblast growth factor 9 in transgenic mice. J Bone Miner Res 1999, 14(11):1909-1915.
44. Govindarajan V, Ito M, Makarenkova HP, Lang RA, Overbeek PA: Endogenous and ectopic gland induction by FGF-10. Dev Biol 2000, 225(1):188-200.
45. Hecht D, Zimmerman N, Bedford M, Avivi A, Yayon A: Identification of fibroblast growth factor 9 (FGF9) as a high affinity, heparin dependent ligand for FGF receptors 3 and 2 but not for FGF receptors 1 and 4. Growth Factors 1995, 12(3):223-233.
46. Overbeek PA, Chepelinsky AB, Khillan JS, Piatigorsky J, Westphal H: Lens-specific expression and developmental regulation of the bacterial chloramphenicol acetyltransferase gene driven by the murine alpha A- crystallin promoter in transgenic mice. Proc Natl Acad Sci U S A 1985, 82(23):7815-7819.
47. Reneker LW, Silversides DW, Patel K, Overbeek PA: TGF alpha can act as a chemoattractant to perioptic mesenchymal cells in developing mouse eyes. Development 1995, 121(6):1669-1680.
48. Nagy A: Manipulating the mouse embryo : a laboratory manual. 3rd edition. Cold Spring Harbor, N.Y. , Cold Spring Harbor Laboratory Press; 2003:x, 764 p..
49. Robinson ML, MacMillan-Crow LA, Thompson JA, Overbeek PA: Expression of a truncated FGF receptor results in defective lens development in transgenic mice. Development 1995, 121(12):3959-3967.
50. Govindarajan V, Overbeek PA: Secreted FGFR3, but not FGFR1, inhibits lens fiber differentiation. Development 2001, 128(9):1617-1627.
51. Wilkinson DG: In situ hybridization : a practical approach. In The practical approach series 196 Oxford ; New York , Oxford University Press; 1998:xviii, 224 p..